Federated Hermes’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Sell
7,998
-93
-1% -$9.54K ﹤0.01% 1184
2025
Q4
$859K Sell
8,091
-907
-10% -$105K ﹤0.01% 1167
2025
Q3
$1.14M Sell
8,998
-412
-4% -$49K ﹤0.01% 1108
2025
Q2
$1.15M Sell
9,410
-130
-1% -$14.8K ﹤0.01% 1094
2025
Q1
$966K Sell
9,540
-1,778
-16% -$174K ﹤0.01% 1115
2024
Q4
$1.05M Buy
11,318
+1,367
+14% +$134K ﹤0.01% 1091
2024
Q3
$962K Sell
9,951
-316
-3% -$28.4K ﹤0.01% 1130
2024
Q2
$881K Sell
10,267
-2,727
-21% -$229K ﹤0.01% 1151
2024
Q1
$1.07M Sell
12,994
-935
-7% -$68.5K ﹤0.01% 1106
2023
Q4
$929K Sell
13,929
-1,471
-10% -$95.3K ﹤0.01% 1163
2023
Q3
$1.03M Buy
15,400
+1,803
+13% +$124K ﹤0.01% 1102
2023
Q2
$921K Sell
13,597
-288
-2% -$18K ﹤0.01% 1162
2023
Q1
$751K Sell
13,885
-295
-2% -$17.2K ﹤0.01% 1268
2022
Q4
$848K Sell
14,180
-1,269
-8% -$69K ﹤0.01% 1190
2022
Q3
$699K Sell
15,449
-5,432
-26% -$272K ﹤0.01% 1237
2022
Q2
$931K Sell
20,881
-1,838
-8% -$94.3K ﹤0.01% 1168
2022
Q1
$1.28M Sell
22,719
-396
-2% -$20.7K ﹤0.01% 1163
2021
Q4
$1.2M Buy
23,115
+818
+4% +$42.2K ﹤0.01% 1213
2021
Q3
$1.33M Sell
22,297
-683
-3% -$43K ﹤0.01% 1176
2021
Q2
$1.43M Sell
22,980
-1,601
-7% -$107K ﹤0.01% 1207
2021
Q1
$1.6M Sell
24,581
-634
-3% -$41.3K ﹤0.01% 1195
2020
Q4
$1.66M Sell
25,215
-1,657
-6% -$97.5K ﹤0.01% 1136
2020
Q3
$1.39M Sell
26,872
-2,973
-10% -$153K ﹤0.01% 1116
2020
Q2
$1.47M Sell
29,845
-1,472
-5% -$79.4K ﹤0.01% 1095
2020
Q1
$1.59M Sell
31,317
-8,529
-21% -$492K ﹤0.01% 963
2019
Q4
$2.19M Sell
39,846
-204,138
-84% -$11.1M ﹤0.01% 999
2019
Q3
$12.3M Sell
243,984
-11,167
-4% -$561K 0.03% 506
2019
Q2
$12.9M Sell
255,151
-3,463
-1% -$168K 0.03% 490
2019
Q1
$12M Buy
258,614
+119,517
+86% +$6.05M 0.03% 495
2018
Q4
$6.83M Buy
139,097
+85,805
+161% +$4.88M 0.02% 642
2018
Q3
$3.31M Sell
53,292
-255,545
-83% -$15.5M 0.01% 926
2018
Q2
$16.6M Sell
308,837
-20,976
-6% -$1.05M 0.05% 301
2018
Q1
$15M Buy
+329,813
New +$14.1M 0.04% 314
2017
Q4
Sell
-61,550
Closed -$2.27M 2192
2017
Q3
$2.27M Buy
61,550
+4,467
+8% +$159K 0.01% 857
2017
Q2
$2.2M Sell
57,083
-4,153
-7% -$152K 0.01% 864
2017
Q1
$2.09M Sell
61,236
-1,224
-2% -$40.2K 0.01% 892
2016
Q4
$2.05M Buy
+62,460
New +$2.03M 0.01% 853
2015
Q2
Sell
-16,572
Closed -$585K 1982
2015
Q1
$585K Sell
16,572
-29,136
-64% -$997K ﹤0.01% 1323
2014
Q4
$1.4M Buy
45,708
+31,905
+231% +$995K ﹤0.01% 1080
2014
Q3
$405K Buy
13,803
+4,250
+44% +$130K ﹤0.01% 1406
2014
Q2
$273K Sell
9,553
-11,174
-54% -$312K ﹤0.01% 1458
2014
Q1
$592K Sell
20,727
-67,297
-76% -$1.75M ﹤0.01% 1301
2013
Q4
$2.33M Buy
88,024
+16,121
+22% +$449K 0.01% 874
2013
Q3
$1.97M Buy
71,903
+47,560
+195% +$1.22M 0.01% 913
2013
Q2
$558K Buy
+24,343
New +$550K ﹤0.01% 1261

Other funds holding EHC

Federated Hermes's EHC Position: Q1 2026 in Review

Federated Hermes reduced its Encompass Health (EHC) stake by 1.1% in Q1 2026, selling an estimated $9.54K and leaving 7,998 shares worth $774K. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

Federated Hermes first reported a position in EHC in Q2 2013 and has held it in 45 quarters since. The position peaked at $16.6M in Q2 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Federated Hermes held 7,998 shares of Encompass Health worth $774K as of Q1 2026.
  • Federated Hermes sold 93 Encompass Health shares in Q1 2026, an estimated $9.54K.
  • Encompass Health made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1184 holding.
  • Federated Hermes first reported a position in Encompass Health in Q2 2013 and has held it in 45 quarters since.
  • Federated Hermes's Encompass Health position peaked at $16.6M in Q2 2018.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.